EHA 2015 | Future perspectives in the treatment of acute lymphoblastic leukemia

Dieter Hoelzer

At the 20th Congress of the European Hematology Association (EHA), Dieter Hoelzer, MD, PhD, of Goethe University Hospital, Frankfurt, Germany, discusses the possibilities of immunotherapy for the treatment of patients with acute lymphoblastic leukemia.

Share this video